Results Snapshot
Figures in Million
Consolidated - Profit And Loss Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
No of Months
12
12
12
12
12
12
Operating Income
1,569.00
1,576.00
1,467.00
1,785.00
1,595.00
1,445.00
Less :Inter divisional transfers
0.00
0.00
0.00
0.00
0.00
0.00
Less: Excise
0.00
0.00
0.00
0.00
0.00
0.00
Net Sales
1,569.00
1,576.00
1,467.00
1,785.00
1,595.00
1,445.00
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
Raw Materials Consumed
0.00
0.00
0.00
0.00
0.00
0.00
Power & Fuel Cost
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
487.00
473.00
452.00
471.00
424.00
403.00
Operating Expenses
30.00
41.00
78.00
67.00
25.00
30.00
General and Administration Expenses
324.00
322.00
325.00
426.00
390.00
346.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Cost of Software developments
0.00
0.00
0.00
0.00
0.00
0.00
Miscellaneous Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Expenses Capitalised
0.00
0.00
0.00
0.00
0.00
0.00
Total Expenditure
1,216.00
1,208.00
1,179.00
1,466.00
1,372.00
1,260.00
Operating Profit (PBDIT) excl Other Income
353.00
368.00
288.00
319.00
222.00
185.00
Other Income
42.00
77.00
52.00
57.00
28.00
19.00
Operating Profit (PBDIT)
549.00
590.00
482.00
560.00
444.00
397.00
Interest
30.00
41.00
78.00
67.00
25.00
30.00
Profit before Depriciation and Tax
0.00
0.00
0.00
0.00
0.00
0.00
Depreciation
153.00
143.00
141.00
184.00
192.00
191.00
Profit Before Taxation & Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
Exceptional Income / Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Profit Before Tax
357.00
373.00
254.00
343.00
235.00
226.00
Provision for Tax
61.00
72.00
44.00
56.00
43.00
34.00
Profit After Tax
301.00
300.00
210.00
251.00
177.00
173.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
Adj to Profit After Tax
0.00
0.00
0.00
0.00
0.00
0.00
Profit Balance B/F
0.00
0.00
0.00
0.00
0.00
0.00
Profit Available for appropriations
0.00
0.00
0.00
0.00
0.00
0.00
Appropriations
0.00
0.00
0.00
0.00
0.00
0.00
Equity Dividend (%)
Earnings Per Share
0.15
0.15
0.12
0.13
0.09
0.09
Profit And Loss Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2026 is -0.47% vs 7.43% in Mar 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2026 is -4.21% vs 27.98% in Mar 2025
Interest
YoY Growth in year ended Mar 2026 is -25.78% vs -47.44% in Mar 2025
Profit After Tax
YoY Growth in year ended Mar 2026 is 0.26% vs 43.09% in Mar 2025
Compare Profit and Loss Results of Jacobson Pharma Corp. Ltd.
Figures in Million
consolidated - Profit And Loss Results
Change(HKD)
Change(%)
No of Months
12
12
Operating Income
1,569.00
834.00
735.00
88.13%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
1,569.00
834.00
735.00
88.13%
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
0.00
0.00
0%
Raw Materials Consumed
0.00
0.00
0.00
0%
Power & Fuel Cost
0.00
0.00
0.00
0%
Employee Cost
487.00
145.00
342.00
235.86%
Operating Expenses
30.00
11.00
19.00
172.73%
General and Administration Expenses
324.00
211.00
113.00
53.55%
Selling and Distribution Expenses
0.00
0.00
0.00
0%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
0.00
0.00
0.00
0%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
1,216.00
580.00
636.00
109.66%
Operating Profit (PBDIT) excl Other Income
353.00
253.00
100.00
39.53%
Other Income
42.00
10.00
32.00
320.00%
Operating Profit (PBDIT)
549.00
313.00
236.00
75.40%
Interest
30.00
11.00
19.00
172.73%
Profit before Depriciation and Tax
0.00
0.00
0.00
0%
Depreciation
153.00
49.00
104.00
212.24%
Profit Before Taxation & Exceptional Items
0.00
0.00
0.00
0%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
357.00
252.00
105.00
41.67%
Provision for Tax
61.00
41.00
20.00
48.78%
Profit After Tax
301.00
201.00
100.00
49.75%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
0.00
0.00
0.00
0%
Profit Available for appropriations
0.00
0.00
0.00
0%
Appropriations
0.00
0.00
0.00
0%
Equity Dividend (%)
0%
0%
0.00
Earnings Per Share
0.151
0.2463
-0.10
-38.69%
Profit And Loss - Net Sales
Net Sales 1,569.46 Million
in Mar 2026Figures in Million
YoY Growth in year ended Mar 2026 is -0.47% vs 7.43% in Mar 2025
Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 353.18 Million
in Mar 2026Figures in Million
YoY Growth in year ended Mar 2026 is -4.21% vs 27.98% in Mar 2025
Profit And Loss - Interest
Interest 30.70 Million
in Mar 2026Figures in Million
YoY Growth in year ended Mar 2026 is -25.78% vs -47.44% in Mar 2025
Profit And Loss - Profit After Tax
Profit After Tax 301.62 Million
in Mar 2026Figures in Million
YoY Growth in year ended Mar 2026 is 0.26% vs 43.09% in Mar 2025






